Can Patients Take Melatonin Before PSG/MSLT?
Patients should NOT take melatonin in the period immediately before polysomnography (PSG) or Multiple Sleep Latency Test (MSLT), as it can interfere with accurate diagnostic testing and interpretation of results.
Rationale for Withholding Melatonin
The primary concern is that melatonin's pharmacologic effects on sleep architecture and latency will confound the diagnostic accuracy of sleep testing:
For MSLT specifically: The test measures physiologic sleep propensity and mean sleep latency to diagnose central disorders of hypersomnolence like narcolepsy. Exogenous melatonin reduces sleep onset latency 1, 2, 3 and could artificially shorten mean sleep latency on the MSLT, potentially leading to false-positive results or misdiagnosis.
For PSG: While less critical than for MSLT, melatonin can alter sleep consolidation and architecture 4, which may affect baseline measurements needed for accurate interpretation.
Pre-Test Preparation Guidelines
The American Academy of Sleep Medicine guidelines emphasize proper preparation before MSLT 5:
- Use actigraphy for 7-14 days prior to PSG/MSLT to objectively document total sleep time and establish habitual sleep-wake patterns 5
- Ensure adequate sleep duration before testing (minimum 7 hours for pediatrics 6, adequate opportunity for adults)
- Document sleep habits objectively rather than relying solely on patient self-report, as patients often overestimate sleep time 7
Medication Considerations
While the guidelines don't explicitly state a washout period for melatonin before PSG/MSLT, the general principle applies:
- Medications that affect sleep architecture or latency should be evaluated and potentially discontinued before diagnostic sleep testing 8
- The clinical evaluation should include detailed substance and medication history 1
- Melatonin has demonstrated effects on sleep onset latency (reducing it by approximately 10 minutes) and sleep consolidation 4
Clinical Context
Important caveats:
- If the patient is being evaluated for circadian rhythm sleep-wake disorders (not hypersomnolence), melatonin use patterns may actually be clinically relevant information 9
- For routine insomnia evaluation, PSG is generally not indicated 1, so this question is less relevant
- The concern is primarily for MSLT testing where precise measurement of physiologic sleep tendency is critical for diagnosis
Practical Recommendation
Discontinue melatonin at least 3-5 days before PSG/MSLT to allow clearance and minimize confounding effects on sleep latency measurements. This timeframe accounts for melatonin's half-life and the need to establish baseline sleep patterns without pharmacologic influence. Document all medication use, including over-the-counter supplements like melatonin, as part of the pre-test evaluation 1.